logo
The 20 best men's skin care products on Amazon, according to dermatologists

The 20 best men's skin care products on Amazon, according to dermatologists

CNN03-07-2025
Men's Amazon skin care quick picks
A cleanser that won't strip your skin: La Roche-Posay Toleriane Hydrating Gentle Cleanser
A bestselling exfoliant: Paula's Choice Skin Perfecting 2% BHA Liquid Exfoliant
A moisturizer that punches above its price: The Ordinary Natural Moisturizing Factors + HA
The best sunscreen we've tested: Murad Multivitamin Clear Coat Broad-Spectrum SPF 50 With some of the best men's skin care available on Amazon, an affordable skin care regimen is just a few clicks away. Yet only 11% of men have a daily skin care routine, according to a 2023 CivicScience survey.
If you count yourself among the majority of guys slacking on grooming, this guide will fix that. Ahead, you'll find everything you need to take care of your skin, including dermatologist- and editor-approved Amazon skin care products that ship straight to your door.
La Roche-Posay Toleriane Hydrating Gentle Cleanser
With its wide availability and derm-approved formulas, La Roche-Posay has become a mainstay in our skin care guides, and the brand's Toleriane cleansers continue that trend. 'This daily gentle cleanser is made with prebiotic thermal spring water, niacinamide and ceramides to effectively wash away dirt, oil and pollutants while maintaining the skin's natural moisture barrier,' said Dr. Brendan Camp, double board-certified dermatologist at MDCS Dermatology. Order it if you have normal or dry skin.
La Roche-Posay Toleriane Purifying Foaming Cleanser
La Roche-Posay's Purifying Cleanser boasts a similar formula with a little extra cleansing oomph for oilier skin types. 'In my experience, men prefer a foaming cleanser, and this one checks all the boxes in terms of leaving the skin feeling refreshed without stripping the barrier,' said Catie Boucher, a board-certified dermatology nurse practitioner and founder of SavvyDerm.
Cetaphil Daily Facial Cleanser
Dr. Marisa Garshick, a board-certified dermatologist at MDCS Dermatology, directed men with normal to oily skin to Cetaphil's Daily Facial Cleanser. 'It contains glycerin, vitamin B3 and vitamin B5, so it won't leave the skin feeling dry while still adequately cleansing,' she said.
Neutrogena Stubborn Texture Daily Cleanser
If there's one product I credit with keeping my skin (mostly) clear, it's this drugstore face wash. Infused with 1% salicylic acid, the foaming formula breaks down excess oil without completely stripping the skin, making it an excellent choice for oily, acne-prone skin types. Read our review
CeraVe Foaming Facial Cleanser
CeraVe is everywhere, and for good reason. Not only are its products affordable and available at most stores, but they also receive high praise from derms like Dr. Noah Gratch, a board-certified dermatologist at MCDS Dermatology. He said CeraVe's Foaming Cleanser works for all skin types, thanks to its fragrance-free, oil-regulating formula that won't dry out the skin.
Kiehl's Facial Fuel Energizing Scrub
Part cleanser, part exfoliator, Kiehl's Facial Fuel Scrub removes dead skin and pollutants while also softening facial hair for a closer shave. As soothing as the menthol and vitamin E formula is, Gratch recommends only using it twice a week.
CeraVe Acne Control Gel
This AHA- and BHA-based gel from CeraVe is Boucher's pick for exfoliation, as it helps 'decongest the pores' while calming and hydrating the skin with niacinamide and hyaluronic acid. Be sure to wear sunscreen after applying.
La Roche-Posay Effaclar Salicylic Acid Acne Treatment
'A few months ago, my brother asked me for the name of my dermatologist so he could get his skin in order ahead of his wedding,' associate deals editor Elena Matarazzo said. The derm's advice? Try this serum to reduce blemishes and pore size. 'He's been using it ever since, along with a gentle cleanser from the brand, and has seen noticeable differences on his cheeks, which were a major problem area during his initial consult with the doctor.'
Paula's Choice Skin Perfecting 2% BHA Liquid Exfoliant
This Amazon bestseller earns a nod from Garshick. With active ingredients like salicylic acid, it helps to fight ingrown hairs, smooth the skin and unclog pores, according to the dermatologist. Start by using it every other day, followed by daily or twice-daily applications.
Kate Somerville ExfoliKate Intensive Exfoliating Treatment
'Used just one to two times a week, this exfoliating treatment eliminates dull skin, removes buildup and reveals smoother, healthier-looking skin,' Camp said. The anti-aging treatment works with the help of ingredients like lactic and salicylic acid, plus soothing aloe vera, honey and vitamin E.
The Ordinary Saccharomyces Ferment 30% Milky Toner
'Though it's not one of beauty editor Sophie Shaw's top products from The Ordinary, I do love the hydrating qualities of this affordable toner,' associate testing writer Joe Bloss said. After cleansing with a face wash, toners like this one can remove dead skin and offer a moisture boost.
The Ordinary Natural Moisturizing Factors + HA
I'm testing this formula for an upcoming story on the best men's moisturizers, and though I've used it before, I'm once again stunned by The Ordinary's price-to-quality ratio. For less than a latte, you get an excellent face moisturizer with clean ingredients that works for nearly all skin types. If you pick one moisturizer, make it this one.
CeraVe Moisturizing Cream
Men looking for a do-it-all moisturizer they can apply everywhere should consider this cream, which topped our testing pool in our review of the best moisturizers for dry skin. Gratch likes that it's lightweight and fragrance-free, so it won't clog pores or irritate sensitive skin.
Vanicream Daily Facial Moisturizer
Free from dyes, fragrances and other irritating ingredients, Vanicream's moisturizer should be a go-to for anyone with eczema or extra-sensitive skin. Camp also commends the product's rich but lightweight texture, which he said is 'formulated with hyaluronic acid and five key ceramides to retain moisture and leave skin feeling soft.'
La Roche-Posay Hyalu B5 Serum
'For men who prefer more of a serum, La Roche-Posay Hyalu B5 is a great option as it allows for easy application, especially for men with facial hair who feel moisturizers get caught in their beard,' Boucher said. She also recommends CeraVe's Oil Control Moisturizing Gel-Cream.
Neutrogena Hydro Boost Hyaluronic Acid Gel Cream
Greasy skin? Try Neutrogena's gel cream, which Garshick said provides moisture while feeling weightless. In our drugstore moisturizer review, our tester confirmed that the gel is very lightweight, making it a great choice for sweltering hot weather and those with normal or combination skin. For best results, apply it to damp skin.
Neutrogena Sport Face Sunscreen SPF 70+
Men's skin is more susceptible to sun damage, Gratch said, so it's vital to add sunscreen to your routine. Neutrogena's Sport Face Sunscreen is his choice, thanks to its lightweight formula that doesn't clog pores.
Murad Multivitamin Clear Coat Broad-Spectrum SPF 50
After our panel tested 25 sunscreens, Murad's lightweight gel stunned us with its invisible application and nourishing skin-perfecting ingredients. It's expensive, but one tester said that just a little bit of the potent formula goes a long way.Read our review
Andalou Naturals Daily Shade + Blue Light Defense Facial Lotion SPF 30
In our roundup of the best face sunscreens, Garshick called this one of her favorite formulas, praising its broad-spectrum protection and its moisture-boosting ingredients.
Supergoop! Mineral Mattescreen SPF 40
Guys may be reluctant to use tinted sunscreen because it seems like makeup, but I've used this formula for years and can confidently say the tint is imperceptible. On top of its invisible, matte application, it's wonderfully light, soaking into greasy skin without adding any oil or heft. The only con is the price. The following FAQs have been answered by clinicians Dr. Brendan Camp and Catie Boucher.
What is the highest-rated men's skin care product on Amazon?
What is the highest-rated men's skin care product on Amazon?
If you filter skin care products by gender on Amazon and sort by bestsellers, you'll find top-rated products from brands like Thayers, Dove Men and Harry's, as well as viral hits like Medicube and Hero Cosmetics. But I'd use our clinicians' picks to steer you in the right direction, given they have the expertise to surface products with science-based ingredients.
What is the best daily skin care routine for men?
What is the best daily skin care routine for men?
A skin care routine doesn't have to be complicated. If you want to stick to the basics, Camp suggests a simple three-step approach. In the morning, cleanse, moisturize and apply sunscreen. (Remember that a moisturizer with SPF can serve two purposes.) In the evening, repeat the same process but skip the sun protection. You can add other products — like toners and exfoliants — gradually, Camp added.
Skin care kits can also be a good starting point, as they often include everything needed for a well-rounded daily regimen.
Still lost? Don't be afraid to ask for help, Boucher said. 'Beyond those essential foundational products, it can be very helpful to schedule a consult with a professional to learn more about how you can best care for your skin in the long term.'
Are there differences between men's and women's skin?
Are there differences between men's and women's skin?
In general, men and women tend to share the same skin care concerns, Boucher said, though guys with facial hair may gravitate to lighter formulations that won't get caught in their beards.
There are, however, some physiological differences. 'The main differences between men's and women's skin is the fact that, as a general rule, men's skin is thicker and produces more oil,' she said. 'While these are key differences to keep in mind when choosing skin care products, marketing tends to put men into a 'one size fits all' box when it comes to their routine.'
For this article, I consulted the following four clinicians to gain their professional insights on men's skin care.
Catie Boucher, board-certified dermatology nurse practitioner and founder of SavvyDerm
Dr. Brendan Camp, double board-certified dermatologist at MDCS Dermatology in New York
Dr. Marisa Garshick, board-certified dermatologist at MDCS Dermatology in New York and New Jersey
Dr. Noah Gratch, board-certified dermatologist at MDCS Dermatology in New York
CNN Underscored has a team of skilled writers and editors who have many years of experience testing, researching and recommending products, and they ensure each article is carefully edited and products are properly vetted. We talk to top experts when applicable to make certain we are testing each product accurately, recommending only the best products and considering the pros and cons of each item.
For this guide, associate writer Maxwell Shukuya leaned on board-certified clinicians and hands-on testing to compile a list of the best men's skin care available on Amazon. Shukuya also brings his own experience as a product tester, having written guides on mineral sunscreens, drugstore face washes and sustainable skin care.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GSK's Blenrep faces setback as FDA cancer committee votes against approval
GSK's Blenrep faces setback as FDA cancer committee votes against approval

Yahoo

time23 minutes ago

  • Yahoo

GSK's Blenrep faces setback as FDA cancer committee votes against approval

The US Food and Drug Administration's (FDA's) Oncologic Drugs Advisory Committee (ODAC) has voted against the benefit/risk profile of GSK's Blenrep (belantamab mafodotin) just days before the drug's Prescription Drug User Fee Act (PDUFA) date. This marks a significant setback for the UK-based pharma company, which is aiming to regain approval of the therapy after it was pulled from the US market in 2022 due to concerns raised by late-stage trial data. Blenrep was approved under the FDA accelerated approval process in 2020 to treat multiple myeloma (MM). It is an antibody drug conjugate (ADC) that combines a humanised BCMA monoclonal antibody with the cytotoxic agent auristatin F, linked together by a non-cleavable linker. The ODAC committee had a 7–1 split against the combination of Blenrep plus pomalidomide and steroid dexamethasone and a 5-3 split against the combination of Blenrep with bortezomib and dexamethasone. GSK states it remains confident in the benefit/risk profile of Blenrep as a combination therapy and will continue to work closely with the FDA as they complete the review of the drug in patients with relapsed or refractory multiple myeloma (r/r MM). The FDA will consider the recommendation of the committee as it finalises its review on Blenrep in advance of the 23 July PDUFA date. The concern of ocular toxicity was first highlighted in a document published ahead of the ODAC meeting that took place on 17 July. The recommendation given by ODACs is usually followed by the FDA when deciding if a drug should be approved. Data supporting the drug's approval comes from the DREAMM-7 (NCT04246047) and DREAMM-8 (NCT04484623) studies. In the studies, many patients experienced keratopathy and Visual Acuity (KVA) events. All grade KVAs occurred in 92% and 93% of patients in DREAMM-7 and DREAMM-8, respectively, while more serious grade 3-4 events were found in 77% and 78% of patients in the same two studies. Blenrep combinations are approved in r/r MM in the UK and Japan, as well as other markets, including Switzerland, based on the results of DREAMM-8. Applications for approval in the European Union (EU) and China are ongoing, based on the results of the DREAMM-7 study. "GSK's Blenrep faces setback as FDA cancer committee votes against approval" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides

Associated Press

time26 minutes ago

  • Associated Press

Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides

WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN ) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, 'Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models.' This patent covers technology developed by that leverages machine learning algorithms, powered by Microsoft (Nasdaq: MSFT ) and Databricks intended to rapidly and accurately identify peptides with strong immune system interactions. Identifying these peptides is critical in developing targeted therapies for a variety of diseases, including cancers and infectious diseases. Traditional methods for identifying immunologically active peptides often face significant limitations, such as overlooking critical human genetic diversity factors like age, sex, race, and ethnicity. proprietary approach may overcome these challenges by: 'I'm pleased with continued progress in strategically harnessing artificial intelligence in support of our cell therapy development,' said Dr. Ryan Saadi, Founder and CEO of Tevogen. 'Leveraging AI to accelerate discovery, shorten development timelines, and reduce costs is essential to our mission of delivering commercially attractive, economically viable, and cost-effective personalized T cell therapies.' Forward Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 [email protected]

Medicaid Enrollment Sees Sharp Decline; HMOs Report $1 Billion Revenue Drop
Medicaid Enrollment Sees Sharp Decline; HMOs Report $1 Billion Revenue Drop

Associated Press

time26 minutes ago

  • Associated Press

Medicaid Enrollment Sees Sharp Decline; HMOs Report $1 Billion Revenue Drop

DUBLIN--(BUSINESS WIRE)--Jul 18, 2025-- The 'Minnesota Health Market Review 2025 (Part 1)' report has been added to offering. HMO profitability plunged in 2024, as HMOs and County-Based Purchasing plans reported lower revenues, higher medical expenses and large losses on operations. The number of enrollees in Medicaid managed care plans dropped by about 207,000 in 2023 and 2024, although it is still higher than before the COVID-19 pandemic. The analyst reports on these and other findings in Part One of Minnesota Health Market Review 2025. This is the 36th edition of the report, which was first published in 1990. The reports in Minnesota and five other states examine key trends and competitive strategies for health plan companies and hospital systems in those markets. Later this year, the Part Two report for Minnesota will present an analysis of the state's hospital systems and how they compete, examining 2024 Medicare cost report data on their financial results and measures of inpatient utilization. The new report finds that: Key Topics Covered: For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: MINNESOTA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: HOSPITALS HEALTH HEALTH INSURANCE SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 07/18/2025 12:41 PM/DISC: 07/18/2025 12:41 PM

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store